The value of GRE, ADC and routine MRI in distinguishing Parkinsonian disorders
- PMID: 23603177
- DOI: 10.1017/s0317167100014360
The value of GRE, ADC and routine MRI in distinguishing Parkinsonian disorders
Abstract
Objectives: To study different radiological signs and sequences including apparent diffusion coefficient (ADC) and gradient echo (GRE) to differentiate degenerative parkinsonian syndromes.
Background: Multiple system atrophy (MSA), Parkinson's disease (PD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CbD) differ in the pattern of neurodegeneration and cellular damage. Measuring the ADC, GRE sequences for paramagnetic substances and simple anatomical assessments have been reported individually to assist in separating some of these disorders, but have not been compared.
Methods: brain MRIs from May 2002 to February 2008 were retrospectively evaluated by raters blinded to the clinical diagnosis for predefined MRI signs on T1, T2 and GRE sequences. ADC values were quantitatively measured. Medical records were objectively analyzed using standard clinical criteria for different parkinsonian syndromes.
Results: 195 cases comprising of 61 PD, 15 MSA-P, 7 MSA-C, 21 PSP, 6 Corticobasal syndrome, 21 not fitting criteria and 64 controls were evaluated. 73% of patients with MSA-P had hypointensity of the putamen (compared to the pallidum) on GRE. The specificity of this sign to diagnose MSA-P was 90% versus PD and 76% versus PSP. When GRE hypointensity was combined with atrophy of the putamen the specificity improved to 98% (versus PD) and 95% (versus PSP) without altering the sensitivity. The ADC values were significantly higher in the middle cerebellar peduncle in cases with MSA-C versus controls, PD and PSP (p<0.001).
Conclusions: The combination of hypointensity and atrophy of the putamen on GRE is useful in differentiating MSA-P from other parkinsonian syndromes.
Similar articles
-
Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.Neuroradiology. 2012 Sep;54(9):947-55. doi: 10.1007/s00234-012-1009-9. Epub 2012 Jan 25. Neuroradiology. 2012. PMID: 22274571
-
Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.Mov Disord. 2007 Jan;22(1):68-74. doi: 10.1002/mds.21204. Mov Disord. 2007. PMID: 17089396
-
Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.Mov Disord. 2006 Jul;21(7):989-96. doi: 10.1002/mds.20877. Mov Disord. 2006. PMID: 16602104
-
The value of novel MRI techniques in Parkinson-plus syndromes: diffusion tensor imaging and anatomical connectivity studies.Rev Neurol (Paris). 2014 Apr;170(4):266-76. doi: 10.1016/j.neurol.2013.10.013. Epub 2014 Mar 20. Rev Neurol (Paris). 2014. PMID: 24656811 Review.
-
[Differential diagnosis of parkinsonian syndromes using MRI].Nervenarzt. 2010 Oct;81(10):1168-79. doi: 10.1007/s00115-010-3022-8. Nervenarzt. 2010. PMID: 20857276 Review. German.
Cited by
-
Diagnostic Performance of Putaminal Hypointensity on Susceptibility MRI in Distinguishing Parkinson Disease from Progressive Supranuclear Palsy: A Meta-Analysis.Mov Disord Clin Pract. 2022 Oct 19;10(2):168-174. doi: 10.1002/mdc3.13573. eCollection 2023 Feb. Mov Disord Clin Pract. 2022. PMID: 36825057 Free PMC article. Review.
-
Differentiation of Parkinson's disease and Parkinsonism predominant multiple system atrophy in early stage by morphometrics in susceptibility weighted imaging.Front Hum Neurosci. 2022 Aug 2;16:806122. doi: 10.3389/fnhum.2022.806122. eCollection 2022. Front Hum Neurosci. 2022. PMID: 35982687 Free PMC article.
-
18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy.J Nucl Med. 2022 Nov;63(11):1754-1760. doi: 10.2967/jnumed.121.262854. Epub 2022 Apr 14. J Nucl Med. 2022. PMID: 35422444 Free PMC article.
-
Diagnostic performance of T2* gradient echo, susceptibility-weighted imaging, and quantitative susceptibility mapping for patients with multiple system atrophy-parkinsonian type: a systematic review and meta-analysis.Eur Radiol. 2022 Jan;32(1):308-318. doi: 10.1007/s00330-021-08174-4. Epub 2021 Jul 16. Eur Radiol. 2022. PMID: 34272590
-
Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.Front Neurol. 2020 Oct 15;11:572976. doi: 10.3389/fneur.2020.572976. eCollection 2020. Front Neurol. 2020. PMID: 33178113 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical
Miscellaneous